Adel A. Marzouk

1.5k total citations
63 papers, 1.2k citations indexed

About

Adel A. Marzouk is a scholar working on Organic Chemistry, Inorganic Chemistry and Molecular Biology. According to data from OpenAlex, Adel A. Marzouk has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Organic Chemistry, 18 papers in Inorganic Chemistry and 17 papers in Molecular Biology. Recurrent topics in Adel A. Marzouk's work include Synthesis and biological activity (35 papers), Crystal structures of chemical compounds (18 papers) and Synthesis and Biological Evaluation (12 papers). Adel A. Marzouk is often cited by papers focused on Synthesis and biological activity (35 papers), Crystal structures of chemical compounds (18 papers) and Synthesis and Biological Evaluation (12 papers). Adel A. Marzouk collaborates with scholars based in Egypt, United Kingdom and Saudi Arabia. Adel A. Marzouk's co-authors include Antar A. Abdelhamid, Ahmed M. Abu‐Dief, Ramadan Ali, Mohamed M. El‐Wekil, Bahaa G. M. Youssif, Ashraf M. Mahmoud, Saad A. Alkahtani, Ayman Nafady, Shaaban K. Mohamed and Mohamed R. Shehata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

Adel A. Marzouk

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adel A. Marzouk Egypt 21 775 330 221 114 109 63 1.2k
Denitsa Yancheva Bulgaria 21 545 0.7× 339 1.0× 87 0.4× 146 1.3× 76 0.7× 106 1.2k
Muhammad Yaqub Pakistan 18 610 0.8× 200 0.6× 248 1.1× 67 0.6× 52 0.5× 67 934
Halil Gökçe Türkiye 23 1.2k 1.6× 152 0.5× 345 1.6× 185 1.6× 84 0.8× 85 1.7k
Marijana Hranjec Croatia 25 1.5k 1.9× 468 1.4× 155 0.7× 240 2.1× 80 0.7× 84 1.9k
Łukasz Popiołek Poland 20 975 1.3× 369 1.1× 243 1.1× 92 0.8× 22 0.2× 65 1.5k
Khalid Mohammed Khan Pakistan 18 1.0k 1.3× 298 0.9× 207 0.9× 91 0.8× 24 0.2× 56 1.3k
Leena Sinha India 20 829 1.1× 127 0.4× 119 0.5× 184 1.6× 70 0.6× 73 1.3k
Raviraj Kusanur India 21 568 0.7× 317 1.0× 85 0.4× 269 2.4× 89 0.8× 77 1.2k
Ümmühan Özdemir Özmen Türkiye 24 841 1.1× 393 1.2× 461 2.1× 262 2.3× 48 0.4× 55 1.4k
S. Kabilan India 28 1.6k 2.0× 470 1.4× 277 1.3× 242 2.1× 136 1.2× 124 2.2k

Countries citing papers authored by Adel A. Marzouk

Since Specialization
Citations

This map shows the geographic impact of Adel A. Marzouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adel A. Marzouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adel A. Marzouk more than expected).

Fields of papers citing papers by Adel A. Marzouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adel A. Marzouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adel A. Marzouk. The network helps show where Adel A. Marzouk may publish in the future.

Co-authorship network of co-authors of Adel A. Marzouk

This figure shows the co-authorship network connecting the top 25 collaborators of Adel A. Marzouk. A scholar is included among the top collaborators of Adel A. Marzouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adel A. Marzouk. Adel A. Marzouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abuo‐Rahma, Gamal El‐Din A., Montaser Sh. A. Shaykoon, Adel A. Marzouk, et al.. (2023). Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition. Bioorganic Chemistry. 134. 106444–106444. 20 indexed citations
3.
Marzouk, Adel A., et al.. (2023). EXPLORING THE PROTEIN KINASE INHIBITORY ACTIVITY OF QUINAZOLINES AS ANTICANCER AGENTS: FDA-APPROVED DRUGS AND PROMISING REPORTED COMPOUNDS. ˜Al-œAzhar Journal of Pharmaceutical Sciences. 68(2). 82–110. 1 indexed citations
4.
Amin, Mohamed A., et al.. (2023). Recent Updates on Synthetic Strategies of Chalcone Scaffold and their Heterocyclic Derivatives. 0(0). 124–132. 3 indexed citations
6.
Marzouk, Adel A., et al.. (2020). Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivatives. Bioorganic Chemistry. 101. 104020–104020. 35 indexed citations
7.
Nemr, Mohamed T. M., Amr Sonousi, & Adel A. Marzouk. (2020). Design, synthesis and antiproliferative evaluation of new tricyclic fused thiazolopyrimidines targeting topoisomerase II: Molecular docking and apoptosis inducing activity. Bioorganic Chemistry. 105. 104446–104446. 41 indexed citations
8.
Marzouk, Adel A., Salah A. Abdel‐Aziz, Kamal Abdelrahman, et al.. (2020). Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation. Bioorganic Chemistry. 102. 104090–104090. 50 indexed citations
9.
Shaykoon, Montaser Sh. A., Adel A. Marzouk, Amira S. Wanas, et al.. (2020). Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives. Bioorganic Chemistry. 100. 103933–103933. 38 indexed citations
10.
Mohamed, Mamdouh F. A., Adel A. Marzouk, Ayman Nafady, et al.. (2020). Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS/PGE2 inhibitors. Bioorganic Chemistry. 105. 104439–104439. 47 indexed citations
11.
Ali, Ramadan, et al.. (2018). Specific stability indicating spectrofluorimetric method for determination of ledipasvir in the presence of its confirmed degradation products; application in human plasma. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 202. 50–57. 9 indexed citations
12.
Simpson, Jim, et al.. (2017). Crystal structure of 1-[2-(4-nitrophenyl)-4,5-diphenyl-1H-imidazol-1-yl]propan-2-ol. Acta Crystallographica Section E Crystallographic Communications. 73(9). 1398–1401. 1 indexed citations
14.
Akkurt, Mehmet, Jerry P. Jasinski, Shaaban K. Mohamed, Adel A. Marzouk, & Mustafa R. Albayati. (2015). Crystal structure of 1-[2-(2,6-dichlorophenyl)-4,5-diphenyl-1H-imidazol-1-yl]propan-2-ol. SHILAP Revista de lepidopterología. 71(5). o299–o300. 2 indexed citations
16.
Akkurt, Mehmet, Shaaban K. Mohamed, Adel A. Marzouk, Vagif М. Abbasov, & Francisco Santoyo‐González. (2013). 2,4,5-Triphenyl-1-(prop-2-en-1-yl)-1H-imidazole. Acta Crystallographica Section E Structure Reports Online. 69(6). o988–o989. 1 indexed citations
17.
Akkurt, Mehmet, et al.. (2013). 2-(2,6-Dichlorophenyl)-1-pentyl-4,5-diphenyl-1H-imidazole. Acta Crystallographica Section E Structure Reports Online. 69(6). o846–o847. 5 indexed citations
18.
Mohamed, Shaaban K., Mehmet Akkurt, Adel A. Marzouk, Kuldip Singh, & Mustafa R. Albayati. (2013). 2-(3,4-Dimethoxyphenyl)-1-pentyl-4,5-diphenyl-1H-imidazole. Acta Crystallographica Section E Structure Reports Online. 69(12). o1833–o1834. 2 indexed citations
19.
Horton, Peter N., et al.. (2012). 1-{(Z)-[3-(1-Hydroxyethyl)anilino]methylidene}naphthalen-2(1H)-one. Acta Crystallographica Section E Structure Reports Online. 69(1). o106–o106. 1 indexed citations
20.
Mohamed, Shaaban K., et al.. (2012). 2-(3,4-Dimethoxyphenyl)-4,5-diphenyl-1-(prop-2-en-1-yl)-1H-imidazole. Acta Crystallographica Section E Structure Reports Online. 68(10). o2979–o2980. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026